Medicines R Us Limited - Limited company - abbreviated - 11.9

Medicines R Us Limited - Limited company - abbreviated - 11.9


07258925 1.6.14 31.5.15 31.5.15 Company accounts Private Limited Company FY true false true false false true false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure072589252014-05-31072589252015-05-31072589252014-06-012015-05-31072589252013-05-31072589252013-06-012014-05-31072589252014-05-3107258925ns12:England2014-06-012015-05-3107258925ns14:PoundSterling2014-06-012015-05-3107258925ns7:Director12014-06-012015-05-3107258925ns7:OrdinaryShareClass12014-06-012015-05-3107258925ns7:Director22014-06-012015-05-3107258925ns7:Director32014-06-012015-05-3107258925ns7:Director42014-06-012015-05-3107258925ns7:Director52014-06-012015-05-3107258925ns7:CompanySecretary2014-06-012015-05-3107258925ns7:RegisteredOffice2014-06-012015-05-3107258925ns7:EntityAccountantsOrAuditors2014-06-012015-05-3107258925ns5:LandBuildingsns5:ShortLeaseholdProperties2014-06-012015-05-3107258925ns5:FixturesFittings2014-06-012015-05-3107258925ns5:FixedAssetInvestmentsOtherThanLoans2015-05-3107258925ns5:FixedAssetInvestmentsOtherThanLoans2014-05-3107258925ns7:OrdinaryShareClass12015-05-3107258925ns7:OrdinaryShareClass12014-05-31
REGISTERED NUMBER: 07258925 (England and Wales)















Abbreviated Unaudited Accounts for the Year Ended 31 May 2015

for

Medicines R Us Limited

Medicines R Us Limited (Registered number: 07258925)

Contents of the Abbreviated Accounts
for the Year Ended 31 May 2015










Page

Company Information 1

Abbreviated Balance Sheet 2

Notes to the Abbreviated Accounts 3

Medicines R Us Limited

Company Information
for the Year Ended 31 May 2015







DIRECTORS: Dr S R Blake
Dr J L Howe
Dr M C Jarvis
Mrs G Sharma
A K Sharma





SECRETARY: Mrs G Sharma





REGISTERED OFFICE: Audit House
260 Field End Road
Eastcote
Middlesex
HA4 9LT





REGISTERED NUMBER: 07258925 (England and Wales)





ACCOUNTANTS: RA Accountants LLP
Chartered Certified Accountants
Audit House
260 Field End Road
Eastcote
Middlesex
HA4 9LT

Medicines R Us Limited (Registered number: 07258925)

Abbreviated Balance Sheet
31 May 2015

31.5.15 31.5.14
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 2 17,718 21,261
Investments 3 100 100
17,818 21,361

CURRENT ASSETS
Stocks 23,891 23,889
Debtors 260,906 277,012
Cash at bank and in hand 91,923 417,676
376,720 718,577
CREDITORS
Amounts falling due within one year 277,615 292,453
NET CURRENT ASSETS 99,105 426,124
TOTAL ASSETS LESS CURRENT
LIABILITIES

116,923

447,485

CAPITAL AND RESERVES
Called up share capital 4 100 100
Profit and loss account 116,823 447,385
SHAREHOLDERS' FUNDS 116,923 447,485

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 May 2015.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 May 2015 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies
Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of
each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections
394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial
statements, so far as applicable to the company.

The abbreviated accounts have been prepared in accordance with the special provisions of Part 15 of the Companies Act 2006 relating to small companies.


The financial statements were approved by the Board of Directors on 20 October 2015 and were signed on its behalf by:



A K Sharma - Director


Medicines R Us Limited (Registered number: 07258925)

Notes to the Abbreviated Accounts
for the Year Ended 31 May 2015


1. ACCOUNTING POLICIES

Accounting convention
The financial statements have been prepared under the historical cost convention and in accordance with the
Financial Reporting Standard for Smaller Entities (effective April 2008).

Turnover
Turnover represents net invoiced sales of goods, excluding value added tax.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Short leasehold - 10% on cost
Fixtures and fittings - 25% on cost

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow
moving items.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance
sheet date.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to the profit and loss account on a straight line basis over the
period of the lease.

2. TANGIBLE FIXED ASSETS
Total
£   
COST
At 1 June 2014
and 31 May 2015 36,454
DEPRECIATION
At 1 June 2014 15,193
Charge for year 3,543
At 31 May 2015 18,736
NET BOOK VALUE
At 31 May 2015 17,718
At 31 May 2014 21,261

Medicines R Us Limited (Registered number: 07258925)

Notes to the Abbreviated Accounts - continued
for the Year Ended 31 May 2015


3. FIXED ASSET INVESTMENTS
Investments
other
than
loans
£   
COST
At 1 June 2014
and 31 May 2015 100
NET BOOK VALUE
At 31 May 2015 100
At 31 May 2014 100

4. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.5.15 31.5.14
value: £    £   
100 Ordinary £1 100 100

5. ULTIMATE PARENT COMPANY

Medicines4U Limited is regarded by the directors as being the company's ultimate parent company.

6. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

At the Balance Sheet date £16,093 was owed to the director A K Sharma.